Comparison between patients with not impaired and impaired admission eGFR regarding treatment, incidence of AKI, length of hospitalization and mortality.

a-eGFR, estimated glomerular filtration rate upon admission (mL/min/1.73 m2); PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers. Continuous variables are presented as median values (with interquartile ranges). Categorical variables are presented as percentages.*With PCI or CABG.†With primary PCI or a thrombolytic.